This document provides a summary of John Paul Hickey's professional experience and qualifications. He is a physician with a master's in public health who currently works at Gilead Sciences discussing their HIV and hepatitis C treatment products. Previously he has worked in clinical roles treating patients with HIV, hepatitis C, and addiction. He has over 10 years of experience in the biopharmaceutical industry establishing relationships with key opinion leaders and presenting clinical data.

1. John Paul Hickey, MD, MPH
140 Cabrini Boulevard #133, New York, NY 10033
Office: (646) 685-0939 • Cell: (917) 596-5963 • Fax: (646) 688-5657
johnpaulhickey646@gmail.com
PROFESSIONAL SUMMARY
I am a physician with a master’s in public health administration and policy, currently
working in the biopharmaceutical industry, at Gilead Sciences, where my role is to
discuss the benefits of the appropriate use of Gilead’s HIV and hepatitis C products. I
draw upon my past clinical experience treating patients with HIV, hepatitis C and
addiction and am considered an expert in these disease states. The information I provide
to healthcare stakeholders results in beneficial clinical outcomes, reduced economic
impact to the healthcare system, and to Gilead’s reputation as a leader in the treatment of
HIV and hepatitis C. My goal is to continue to add value to individual clinical outcomes,
population health and reduced health care costs.
AREAS OF EXPERTISE
HIV, hepatitis C, addiction medicine, health administration and policy, health economics
PROFESSIONAL EXPERIENCE
Associate Director, HIV Medical Affairs
Gilead Sciences, Foster City, CA, April 2011 to present
My primary role is to establish and maintain peer-peer relationships with infectious
disease key opinion leaders and researchers at major academic institutions and clinics. I
act as a conduit of information about Gilead’s HIV and hepatitis C research
developments, clinical trial activities and pipeline products. I translate the dense,
scientific data that supports Gilead’s HIV and hepatitis C products into engaging,
persuasive messages.
• Collaborate with HIV and hepatitis C key opinion leaders, physicians and other
health care professionals to discuss the most current Gilead data.
• Attend scientific conferences, collect pertinent data and present it to key opinion
leaders, researchers, clinicians and healthcare organizations.
• Lead workshops at national speaker meetings and advisory boards to disseminate
pipeline product data.
• Collaborate with managed markets team to disseminate data about the economic
benefits of Gilead’s products to audiences that include third party payers and
hospital formulary committees.
• Edit manuscripts for publication in collaboration with clinical research and
medical affairs colleagues.

2. • Train and support consulting speakers on the latest Gilead data.
• Evaluate investigator-led, phase 4 clinical research proposals.
• Attend HIV resistance-focused scientific meetings, develop post-conference
summaries and lead internal HIV resistance conferences.
• Lead presentations on FDA label indications to commercial, marketing and sales
colleagues after drug approvals.
Regional Director, Medical Affairs
Monogram Biosciences, South San Francisco, CA, July 2008 to April 2011
My job involved cultivating and maintaining relationships with academic researchers and
leaders, attending scientific conferences, and presenting data about Monogram’s HIV
resistance assays to physicians and other healthcare professionals. I helped to ensure that
Monogram’s assays were utilized effectively. I served as an HIV resistance expert within
the HIV medical community.
• Identified key opinion leaders, provided most current data and supported their
Monogram related presentations.
• Developed HIV resistance and tropism focused presentations, including CME-
qualifying activities.
• Presented HIV resistance and tropism data to HIV opinion leaders and providers.
• Attended virology and oncology scientific conferences and provided external and
internal post-conference updates.
• Led field and in-house training in the areas of HIV, hepatitis C and breast cancer.
• Evaluated investigator-led clinical research proposals.
• Directed internal educational programs for the commercial team.
• Ensured product compliance with regulatory requirements and professional
recommendations.
APPOINTMENTS
Medical Director
The Wellness Center Clinic, Bronx Lebanon Hospital Center, Bronx, NY, Departments of
Internal Medicine and Psychiatry, March 2006 to July 2008
• Oversaw training and education of staff physicians.
• Ensured compliance with regulatory requirements.
• Provided patient care in the areas of HIV, primary care and addiction medicine.
Staff Physician, HIV Specialist
Callen-Lorde Community Health Center, New York, NY, February 2004 to March 2006
• Provided patient care in the areas of HIV/AIDS, general primary care, transgender
medicine and sexual health screening and treatment.
• Coordinated volunteer medical providers, residents, and medical students.
Quality Assurance Administrator
The Floating Hospital, New York, NY, 2004 to 2007

3. • Analyzed patient records for quality assurance and improvement.
Attending Physician
Metropolitan Hospital Center, New York, NY, Departments of Internal Medicine and
Pediatrics, July 2002 to February 2004
• Directed and trained internal medicine and pediatric house staff.
• Provided outpatient adult and pediatric primary care.
Assistant Professor
New York Medical College, Valhalla, NY, Departments of Internal Medicine and
Pediatrics, July 2002 to February 2004
• Taught internal medicine and pediatric residents and interns.
POST-DOCTORAL TRAINING
Resident, Internal Medicine-Pediatrics
Saint Vincent’s Hospital and Medical Center
New York, NY, July 1999 - June 2002
Intern, Internal Medicine-Pediatrics
Saint Vincent’s Hospital and Medical Center
New York, NY, July 1998 - June 1999
EDUCATION
Doctor of Medicine
State University of New York at Stony Brook School of Medicine
Stony Brook, NY, May 1998
Master of Public Health
University of North Carolina, Chapel Hill School of Public Health
Chapel Hill, NC, April, 2010
Bachelor of Science
City College of the City University of New York, School of Architecture and
Environmental Planning, New York, NY, June 19851
LICENSE AND CREDENTIALING
New York State, License #223692
American Academy of HIV Expert
RESEARCH/ABSTRACTS
Co-author
Switching to STB from a RTV-boosted PI or NNRTI with TVD maintains HIV
suppression at week 48 with no new safety signals in subjects age >50 Years

4. Presented at 5th
International Workshop on HIV and Aging, Oct 2014, Baltimore, MD
Sub-investigator
Early Access of TMC114 in combination with low-dose Ritonavir and other
antiretrovirals in highly treatment experienced HIV-1 infected patients with limited or no
treatment options. Study ID number: CR006778, TMC114-C202, Clinicaltrials.gov
identifier: NCT00071097
Sub-investigator
Combination of Efavirenz & Truvada (COMET) study. Study ID number: GS-US-164-
0107, Clinicaltrials.gov identifier: NCT00224458
Sub-investigator
Head to head Epzicom and Truvada (HEAT) study. Study ID number: EPZ104057,
Clinicaltrials.gov identifier: NCT00244712
Co-investigator
A Phase II, double-blind, placebo-controlled dose ranging study of the antiretroviral
activity and safety of DMP 266 in combination with open-label zidovudine and
lamivudine in HIV infected patients without prior therapy.
OTHER EDUCATION AND EXPERIENCE
Post-Baccalaureate
California State University, San Francisco, CA, 1991-1993
Community AIDS Educator
AIDS Community Teaching Program, Suffolk County, NY, 1995-1996
• Led discussions and provided HIV/AIDS education to high school students.
Preceptee, AIDS Education and Teaching Program
Saint Vincent’s Hospital and Medical Center, Primary Care Preceptorship, New York,
NY, July-August, 1995
Job Captain
Gap, Incorporated, San Francisco, CA, Department of Store Design, 1988-1994
Project Coordinator
Gibson Bauer Associates Architects, New York, NY, 1987
Project Coordinator
Seelye Stevenson Value and Knecht Engineers, New York, NY, 1983-1987